| RS1737429976 |
PDE6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 40 |
| RS1737442897 |
PDE6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa |
| RS1737453248 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS1737457235 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS1737495759 |
NRROS
|
Health Risk |
Pathogenic |
Seizures, early-onset |
| RS1737503567 |
PDE6B
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1737597490 |
WDFY3
|
Health Risk |
Pathogenic |
— |
| RS1737672350 |
NRROS
|
Health Risk |
Pathogenic |
Seizures, early-onset |
| RS1737677036 |
NRROS
|
Health Risk |
Pathogenic |
Seizures, early-onset |
| RS1737685202 |
NRROS
|
Health Risk |
Likely pathogenic |
Seizures, early-onset |
| RS1737818730 |
MTRR
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS1737852706 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1737854315 |
MTRR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS1737950162 |
MSX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoplastic enamel-onycholysis-hypohidrosis syndrome, Tooth agenesis |
| RS1737950187 |
MSX1
|
Health Risk |
Pathogenic |
Hypoplastic enamel-onycholysis-hypohidrosis syndrome, Hypoplastic enamel-onycholysis-hypohidrosis syndrome |
| RS1737950636 |
MSX1
|
Health Risk |
Pathogenic |
Hypoplastic enamel-onycholysis-hypohidrosis syndrome, Hypoplastic enamel-onycholysis-hypohidrosis syndrome |
| RS1737970426 |
FBXW7
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1737980148 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1738418070 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1738565324 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS1738612312 |
ENAM
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta - hypoplastic autosomal dominant - local, Amelogenesis imperfecta - hypoplastic autosomal dominant - local |
| RS1738618466 |
RETREG1
|
Health Risk |
Pathogenic |
— |
| RS1738621357 |
ENAM
|
Health Risk |
Likely pathogenic |
— |
| RS1738646700 |
RETREG1
|
Health Risk |
Pathogenic |
— |
| RS1738673948 |
CNGA1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1738688368 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1738695332 |
MTRR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS1738698692 |
CNGA1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1738701040 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 49, Retinitis pigmentosa 49 |
| RS1738719686 |
CNGA1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1739025907 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1739215940 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1739238968 |
SNCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 1, Autosomal dominant Parkinson disease 1 |
| RS1739374011 |
SPEF2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1739469293 |
RPGRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Cone-rod dystrophy 13 |
| RS1739482158 |
CLN5
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 5 |
| RS1739558635 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS1739594685 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Late-infantile neuronal ceroid lipofuscinosis |
| RS1739624229 |
NNT
|
Health Risk |
Likely pathogenic |
Glucocorticoid deficiency 4, Glucocorticoid deficiency 4 |
| RS1739691061 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 24 |
| RS1739770567 |
ITGB3
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 2 |
| RS1739811126 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS1739959023 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1739974269 |
F11
|
Health Risk |
Pathogenic |
— |
| RS1740022320 |
FAT1
|
Health Risk |
Likely pathogenic |
— |
| RS1740078926 |
C7
|
Health Risk |
Pathogenic |
— |
| RS1740083267 |
C7
|
Health Risk |
Pathogenic |
— |
| RS1740105027 |
F11
|
Health Risk |
Pathogenic |
— |
| RS1740186895 |
FGF10
|
Health Risk |
Likely pathogenic |
Orofacial cleft 1, Orofacial cleft 1 |
| RS1740201702 |
F11
|
Health Risk |
Pathogenic |
— |
| RS1740291234 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1740380459 |
RPGRIP1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1740436185 |
C7
|
Health Risk |
Likely pathogenic |
— |
| RS1740652803 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1740702281 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1740724748 |
C7
|
Health Risk |
Likely pathogenic |
— |
| RS1740730588 |
NDUFS4
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS1740799305 |
TBCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, infantile |
| RS1740842785 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1740845459 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1740904060 |
MOCS2
|
Health Risk |
Pathogenic |
Combined molybdoflavoprotein enzyme deficiency, Combined molybdoflavoprotein enzyme deficiency |
| RS1740929756 |
MOCS2
|
Health Risk |
Pathogenic |
— |
| RS1740933642 |
MOCS2
|
Health Risk |
Likely pathogenic |
Combined molybdoflavoprotein enzyme deficiency, Combined molybdoflavoprotein enzyme deficiency |
| RS1741002305 |
F11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1741117263 |
MOCS2
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS1741122462 |
BLTP1
|
Health Risk |
Likely pathogenic |
Severe hydrocephalus, Arthrogryposis multiplex congenita |
| RS1741165195 |
F11
|
Health Risk |
Pathogenic |
— |
| RS1741183871 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1741192008 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1741382224 |
F11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1741388544 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1741436306 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1741445944 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1741461840 |
NFKB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency, common variable |
| RS1741466817 |
AFG2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1741493255 |
NNT
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1741916135 |
GPR179
|
Health Risk |
Likely pathogenic |
— |
| RS1741953064 |
NPR3
|
Health Risk |
Likely pathogenic |
Boudin-Mortier syndrome, Boudin-Mortier syndrome |
| RS1741984828 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1741988534 |
RETREG1
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1742074967 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS1742088018 |
DNAH5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1742093744 |
DNAH5
|
Health Risk |
Pathogenic |
— |
| RS17425208 |
FRG1
|
Health Risk |
Pathogenic |
Pulmonary artery atresia, Pulmonary artery atresia |
| RS17425877 |
UROS
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutaneous porphyria, Cutaneous porphyria |
| RS1742717583 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1743016889 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Hereditary cancer-predisposing syndrome |
| RS1743038020 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1743041017 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1743097125 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1743147822 |
CWC27
|
Health Risk |
Likely pathogenic |
— |
| RS1743272091 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1743273111 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS1743273255 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1743273324 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS1743299340 |
SCLT1
|
Health Risk |
Pathogenic |
SCLT1-related disorder, SCLT1-related disorder |
| RS1743352460 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS1743353294 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS1743355453 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Endometrial carcinoma |
| RS1743358464 |
PDE4D
|
Health Risk |
Likely pathogenic |
Acrodysostosis 2 with or without hormone resistance, Acrodysostosis 2 with or without hormone resistance |